Home biotech
 

Keywords :   


Tag: biotech

Arrowhead to Present at BioCentury's NewsMakers in the Biotech Industry Conference

2014-09-20 00:55:19| Biotech - Topix.net

Arrowhead Research Corporation , a biopharmaceutical company developing targeted RNAi therapeutics, today announced that Bruce Given, M.D., Arrowhead's chief operating officer, will present at BioCentury's 21st Annual NewsMakers in the Biotech Industry conference on September 26, 2014 at 10:30 a.m. EDT in New York. Investors may access a live and archived audio webcast on the Company's website at http://ir.arrowhedresearch.com/events.cfm .

Tags: present industry conference biotech

 

Food, biotech groups give $1M against Measure 92

2014-09-19 11:14:30| Food - Topix.net

As expected, many of the nation's largest food companies are weighing in with contributions against Measure 92, which would require labeling of genetically modified food products in Oregon. So far the No on 92 campaign has raised more than $1 million, about $800,000 of which is still on hand, according to the Oregon Elections Division Orestar system.

Tags: give groups food measure

 
 

Oncolytics Biotech Receives Buy Rating from Paradigm Capital

2014-09-17 19:36:48| Biotech - Topix.net

's stock had its "buy" rating reissued by investment analysts at Paradigm Capital in a note issued to investors on Wednesday. They currently have a C$8.00 price objective on the stock, down from their previous price objective of C$10.00.

Tags: buy rating capital receives

 

How cost pressures under Obamacare can be a boon to the biotech industry

2014-09-16 22:22:54| Biotech - Topix.net

President Barack Obama's signature Affordable Care Act has spurred plenty of attacks on the pharmaceutical industry, but it has also created opportunities, according to Flagship Ventures partner Harry Wilcox. The recent launches of drugs with high up-front costs have revived the longstanding debate over how much new medicines ought to cost.

Tags: to the cost industry

 

Cost a focus as GSK takes lead in new wave of biotech lung drugs

2014-09-08 18:10:50| Biotech - Topix.net

Cost-effectiveness is seen as a challenge for a new group of biotech lung drugs that have produced promising results in clinical tests, of which the first is likely to be launched next year by GlaxoSmithKline. Rival firms are racing to develop similar injectable drugs for patients with severe asthma, who do not respond adequately to traditional inhalers, in pursuit of a new market that analysts believe may be worth around $7.5 billion in annual sales.

Tags: of cost lead takes

 

Sites : [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] next »